Details of the Drug

General Information of Drug (ID: DMR4E1C)

Drug Name
ZYI-1
Indication
Disease Entry ICD 11 Status REF
Inflammation 1A00-CA43.1 Phase 2 [1]
Cross-matching ID
TTD ID
D0B1RX

References

1 Clinical pipeline report, company report or official report of Zydus-Cadila Group.